University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
272 Ergebnisse für "decided" unter University of Zurich
UZH - Student Advisory Services - I’ve Decided to Study!
... UZH - Student Advisory Services - I’ve Decided to Study! ... UZH - Student Advisory Services - I’ve Decided to Study! Home Main navigation Search Jump to ... UZH - Student Advisory Services - I’ve Decided to Study! ...
UZH - Institute of Biomedical Ethics and History of Medicine (IBME)...
... . She started her professional life as a pharmacist and then decided to concentrate her efforts on ... Medical City (KFMC) in Riyadh. With the expansion of the research activities at the KFMC, she decided to ... her professional life as a pharmacist and then decided to concentrate her efforts on research ... (KFMC) in Riyadh. With the expansion of the research activities at the KFMC, she decided to specialize ...
Molecular Partners AG
http://www.molecularpartners.com
8952 Schlieren, Wagistrasse 14
+41 44 755 77 00
Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.
Molecular Partners AG
Wagistrasse 14
8952 Schlieren
9 Ergebnisse für "decided" unter Molecular Partners AG
Comments on: Christian Zahnd appointed as Honorary Chairman of the ...
... Comments on: Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided ... Comments on: Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided not to ... Comments on: Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided ... -directors-as-he- decided-not-to-stand-for-re-election-as-member-of-the-board-of-directors-at-the-annual ... Comments on: Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided ...
Shareholders of Molecular Partners AG approved all Board proposals ...
... decided not to stand for re-election. Jörn Aldag, Chairman of Molecular Partners commented: “We are very ... Rubertis who decided not to stand for re-election. Jörn Aldag, Chairman of Molecular Partners commented ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
424 Ergebnisse für "decided" unter ETH Entrepreneurship
January 2019
... with our old one. This is a work in progress but we’ve already decided to put it online to display some ... with our old one. This is a work in progress but we’ve already decided to put it online to display some ...
Yanxia joins the lab – Soft and Living Materials | ETH Zurich
... mechanical behavior of soft materials. After her graduation, she thus decided to join the group as a PhD ... . After her graduation, she thus decided to join the group as a PhD student. Welcome, Yanxia! Additional ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
260 Ergebnisse für "decided" unter Somagenetix
UZH - Department of Computational Linguistics - XVII AISV Conference
... Organizing Committee has decided to host the Conference in a virtual format. Digital attendance will be ... epidemic developments in the coming months, the Organizing Committee has decided to host the Conference in ...
UZH - Faculty of Science - Nuclearia is protist of the year 2019 de...
... (DGP) decided in favor of UZH-researcher Thomas Posch and declared Nuclearia to be the protist of the ... DGP The German Society for Protozoology (DGP) decided in favor of UZH-researcher Thomas Posch and ...
SecureCell AG
8902 Urdorf, In der Luberzen 29
+41 44 732 91 00
contact@securecell.ch
Securecell is pioneering the world’s next solutions for global biotech and MedTech systems. From automated bioprocessing and smart pharmacological facilities to the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems. At Securecell we believe the best future should be our next future, hence our technologies represent innovative solutions that can improve lives on a global scale.
SecureCell AG
In der Luberzen 29
8902 Urdorf
1 Ergebnisse für "decided" unter SecureCell AG
Securecell | Modular Sampling System – Tape Filtration Module
... process satisfactorily. That's why we decided to further develop our filtration module. The underlying ... automating this process satisfactorily. That's why we decided to further develop our filtration module. The ...
GlycoEra AG
8952 Schlieren, Grabenstrasse 3
+41 44 733 85 75
info@glycoera.com
GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra’s platform has overcome these challenges! The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.
GlycoEra AG
Grabenstrasse 3
8952 Schlieren
13 Ergebnisse für "decided" unter GlycoEra AG
Chemistry – GlycoEra
... Lorem Ipsum decided to leave for the far World of Grammar. The Big Oxmox advised her not to do so ... blind text by the name of Lorem Ipsum decided to leave for the far World of Grammar. The Big Oxmox ... orthographic life One day however a small line of blind text by the name of Lorem Ipsum decided to leave for ... by the name of Lorem Ipsum decided to leave for the far World of Grammar. The Big Oxmox advised her ...
Equipment – GlycoEra
... Lorem Ipsum decided to leave for the far World of Grammar. The Big Oxmox advised her not to do so ... blind text by the name of Lorem Ipsum decided to leave for the far World of Grammar. The Big Oxmox ... orthographic life One day however a small line of blind text by the name of Lorem Ipsum decided to leave for ... by the name of Lorem Ipsum decided to leave for the far World of Grammar. The Big Oxmox advised her ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
4 Ergebnisse für "decided" unter Neurimmune Therapeutics AG
Neurimmune - 03.11.2008: New facility at the Bio-Technopark Zurich ...
... laboratories for its future development, Neurimmune decided to relocate from its current facility at the ... for its future development, Neurimmune decided to relocate from its current facility at the University ...
Neurimmune - 03.11.2008: New facility at the Bio-Technopark Zurich ...
... laboratories for its future development, Neurimmune decided to relocate from its current facility at the ... laboratories for its future development, Neurimmune decided to relocate from its current facility at the ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
6 Ergebnisse für "decided" unter Bio-Technopark Schlieren-Zürich
Patrick Amstutz Appointed as Chief Executive Officer › BIO-TECHNOPA...
... announced that the Board of Directors unanimously decided to appoint Patrick Amstutz, Ph.D., co-founder of ... of Directors unanimously decided to appoint Patrick Amstutz, Ph.D., co-founder of the company, as ...
Biogen and Eisai to discontinue Phase 3 ENGAGE and EMERGE trials of...
... / ZURICH, SWITZERLAND – March 21, 2019 – Neurimmune today informed that Biogen and Eisai decided to ... SCHLIEREN / ZURICH, SWITZERLAND – March 21, 2019 – Neurimmune today informed that Biogen and Eisai decided ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
45 Ergebnisse für "decided" unter Roche Glycart AG
Philanthropic Initiatives - Code of Conduct
... , contributing to water and habitat activities in several countries around the world. Initiatives are decided in ... club asking Roche for a financial donation. What do I do? Philanthropic donations are decided by local ... water and habitat activities in several countries around the world. Initiatives are decided in line with ... donation. What do I do? Philanthropic donations are decided by local management of the affiliate concerned ...
Roche - The voice of Kwang Ooi Tan
... Electrical and Electronics Engineering as well as a post graduate degree in Logistics. Kwang Ooi decided to ... Electronics Engineering as well as a post graduate degree in Logistics. Kwang Ooi decided to join Roche ...
Standortförderung Kanton Zürich
https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html
8090 Zürich, Walchestrasse 19
+41 43 259 49 92
standort@vd.zh.ch
The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.
Standortförderung Kanton Zürich
Walchestrasse 19
8090 Zürich
9 Ergebnisse für "decided" unter Standortförderung Kanton Zürich
UK Citizens | Kanton Zürich
... for third-country nationals. The Federal Council has decided to create separate quotas for UK citizens ... for third-country nationals. The Federal Council has decided to create separate quotas for UK citizens ...
Quotas 2024 | Kanton Zürich
... enable companies based in Switzerland to recruit specialists from the UK, the Federal Council decided to ... in Switzerland to recruit specialists from the UK, the Federal Council decided to set maximum quotas ...